Open access · CC-BY
via OpenAlex
The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link
Laura W. Bowers, Emily L. Rossi, Ciara H. Oâ€TMFlanagan, Linda A. deGraffenried, Stephen David Hursting
Frontiers in Endocrinology · 2015 · ▲ 173 citations
Abstract
Numerous epidemiological and pre-clinical studies have demonstrated that the insulin/insulin-like growth factor (IGF) system plays a key role in the development and progression of several types of cancer. Insulin/IGF signaling, in cooperation with chronic low-grade inflammation, is also an important contributor to the cancer-promoting effects of obesity. However, clinical trials for drugs targeting different components of this system have produced largely disappointing results, possibly due to the lack of predictive biomarker use and problems with the design of combination therapy regimens. With careful attention to the identification of likely patient responders and optimal drug combinations, the outcome of future trials may be improved. Given that insulin/IGF signaling is known to contribute to obesity-associated cancer, further investigation regarding the efficacy of drugs targeting this system and its downstream effectors in the obese patient population is warranted.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fendo.2015.00077
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Bowers, L.W., Rossi, E.L., Oâ€TMFlanagan, C.H., deGraffenried, L.A., & Hursting, S.D. (2015). The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. <em>Frontiers in Endocrinology</em>. https://doi.org/10.3389/fendo.2015.00077
Vancouver
Bowers LW, Rossi EL, Oâ€TMFlanagan CH, deGraffenried LA, Hursting SD. The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Frontiers in Endocrinology. 2015. doi:10.3389/fendo.2015.00077.
BibTeX
@article{laura2015TheRol,
title = {The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link},
author = {Laura W. Bowers and Emily L. Rossi and Ciara H. Oâ€TMFlanagan and Linda A. deGraffenried and Stephen David Hursting},
journal = {Frontiers in Endocrinology},
year = {2015},
doi = {10.3389/fendo.2015.00077},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Biological Sciences 2023
Open access · CC-BY
IGF/IGF-1R signal pathway in pain: a promising therapeutic target
BMC Cancer 2021
Open access · CC-BY
Gut microbiome and its role in colorectal cancer
British Journal of Cancer 2010
Open access · CC-BY
Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer
Cells 2021
Open access · CC-BY
Senescent Cells in Cancer: Wanted or Unwanted Citizens
Biochemical and Biophysical Research Communications 2024
Citation only
Insulin and IGF-1 extend the lifespan of Caenorhabditis elegans by inhibiting insulin/insulin-like signaling and mTOR signaling pathways: C. elegans - Focused cancer research
Critical Reviews in Oncology/Hematology 2013
Preprint · OA